BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35692019)

  • 1. [Global guidelines for cervical cancer and precancerous lesions treatment: a systematic review].
    Zhao S; Chen H; Zhao FH
    Zhonghua Yi Xue Za Zhi; 2022 Jun; 102(22):1666-1676. PubMed ID: 35692019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.
    Al-Mandeel HM; Sagr E; Sait K; Latifah HM; Al-Obaid A; Al-Badawi IA; Alkushi AO; Salem H; Massoudi NS; Schunemann H; Mustafa RA; Brignardello-Petersen R
    Ann Saudi Med; 2016; 36(5):313-320. PubMed ID: 27710981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical research progress and implications of therapeutic vaccines for cervical cancer and precancerous lesions: a qualitative systematic review].
    Cai S; Miao K; Tan XY; Cheng S; Li DT; Zeng XY; Yang Y; Meng RR; Liu ZK; Li Y; Li KL; Sun F; Zhan SY
    Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):743-760. PubMed ID: 35880341
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of CIN1].
    Rouzier R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S114-20. PubMed ID: 18191500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.
    Kreimer AR; Schiffman M; Herrero R; Hildesheim A; González P; Burk RD; Porras C; Sherman ME; Demuth F; Cheung L; Bratti C; Cecilia Rodríguez A
    Int J Cancer; 2012 Jul; 131(1):211-8. PubMed ID: 21823117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative approach to preneoplastic cervical lesions in postmenopause.
    Vetrano G; Aleandri V; Ciolli P; Scardamaglia P; Pacchiarotti A; Verrico M; Carboni S; Corosu R
    Anticancer Res; 2008; 28(6B):3941-4. PubMed ID: 19192654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Diagnostic Potential of EPB41L3 Methylation in Cervical Cancer and Precancerous Lesions: A Systematic Review and Meta-Analysis.
    Sha Y; Liu Y; Yang X; Wang J; Zhang R; Shen F
    Gynecol Obstet Invest; 2024; 89(1):1-10. PubMed ID: 38081153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Precancerous lesions of the uterine cervix: morphology and molecular pathology].
    Horn LC; Klostermann K
    Pathologe; 2011 Nov; 32 Suppl 2():242-54. PubMed ID: 21909794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
    Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
    JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of cervical premalignant lesions.
    Basu P; Taghavi K; Hu SY; Mogri S; Joshi S
    Curr Probl Cancer; 2018; 42(2):129-136. PubMed ID: 29428790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
    Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
    Salvadó A; Miralpeix E; Solé-Sedeno JM; Kanjou N; Lloveras B; Duran X; Mancebo G
    Gynecol Oncol; 2021 Sep; 162(3):569-574. PubMed ID: 34226019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of precancerous cervical lesions in iran: a cost minimizing study.
    Nahvijou A; Sari AA; Zendehdel K; Marnani AB
    Asian Pac J Cancer Prev; 2014; 15(19):8209-13. PubMed ID: 25339007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.